Breaking News Instant updates and real-time market news.

HD

Home Depot

$188.02

-3.13 (-1.64%)

, BA

Boeing

$342.13

-2.26 (-0.66%)

16:23
05/15/18
05/15
16:23
05/15/18
16:23

On The Fly: Top stock stories for Tuesday

Stocks opened in negative territory with the early weakness attributed to a rise in interest rates and a mixed earnings report from Dow component Home Depot (HD). There was little impact from the day's economic reports, including a better than expected report on manufacturing as well as the housing market index. The selling pressure remained as the day progressed, as investors booked profits after the market's recent run-up. ECONOMIC EVENTS: In the U.S., retail sales rose 0.3% in April, matching economists' consensus view. The Empire state manufacturing index bounced 4.3 points to 20.1 in May, which was better than expected. Business inventories were flat in March, with sales up 0.5%. A housing index kept by the National Association of Home Builders rose one point to a reading of 70 for May. COMPANY NEWS: Shares of Home Depot slid 1.6% after softer seasonal sales impacted by weather caused the home improvement giant's revenue to miss expectations in the first quarter. Of note, Home Depot's same-store sales growth of 4.2% in the quarter came in below the company's full-year forecast for same-store sales to rise 5% compared to last year... Boeing (BA) noted that the World Trade Organization issued its final decision in a case brought by the U.S. and the aircraft maker, stating that "the WTO has determined the EU must end its unfair business practices and remedy the ongoing harm caused by the illegal subsidies." Boeing added that the ruling "clears the way for the United States Trade Representative to seek remedies in the form of tariffs against European imports to the United States [that] are likely to total billions in duties per year, unless and until Airbus addresses the illegal subsidies it received from European governments for its most recently launched airplanes"... Tesla (TSLA) shares were 2.7% lower after Reuters reported that the car maker plans to temporarily halt production at its California factory for six days at the end of May to work on fixes to its assembly line for its new Model 3 sedan. Additionally, Morgan Stanley analyst Adam Jonas made significant cuts to his near-term and long-term auto margin forecasts and cut his price target on the stock down to $291 from $376... SQM (SQM) shares rose 2% after Reuters reported that China's Tianqi Lithium is close to a deal to acquire a 24% stake in SQM for roughly $4.3B. Tianqi is set to sign an agreement to buy the SQM stake from Nutrien (NTR), pushing ahead despite Chilean government opposition to a transaction with a Chinese company, the report noted. Nutrien finished the day about 2% higher following the report as well. MAJOR MOVERS: Among the noteworthy gainers was Hollysys Automation (HOLI), which rose 13% after its Q3 report prompted upgrades of the stock at Citi and JPMorgan. Also higher was Valeant (VRX), which gained 3.6% after Mizuho analyst Irina Koffler upgraded the stock to Buy from Neutral. Among the notable losers were Vipshop (VIPS) and Agilent (A), which fell a respective 20% and 10% after reporting quarterly results. INDEXES: The Dow fell 193.00, or 0.78%, to 24,706.41, the Nasdaq lost 59.69, or 0.81%, to 7,351.63, and the S&P 500 declined 18.68, or 0.68%, to 2,711.45.

HD

Home Depot

$188.02

-3.13 (-1.64%)

BA

Boeing

$342.13

-2.26 (-0.66%)

TSLA

Tesla

$284.15

-7.69 (-2.64%)

SQM

SQM

$57.25

1.26 (2.25%)

NTR

Nutrien

$51.73

1.21 (2.40%)

HOLI

Hollysys

$24.96

2.86 (12.94%)

VRX

Valeant

$21.53

0.73 (3.51%)

VIPS

Vipshop

$12.08

-3.02 (-20.00%)

A

Agilent

$62.52

-6.72 (-9.71%)

  • 15

    May

  • 15

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 30

    May

  • 31

    May

  • 18

    Jun

  • 27

    Aug

HD Home Depot
$188.02

-3.13 (-1.64%)

05/15/18
LOOP
05/15/18
NO CHANGE
Target $187
LOOP
Home Depot reported 'mixed' Q1 'at best,' says Loop Capital
Loop Capital analyst Laura Champine views Home Depot's Q1 report as a "mixed performance, at best." Home Depot's same-store-sales of 4.2% missed the analyst's estimate of 5%, but she notes the weakness was anticipated given weather trends in the quarter. Further, Champine notes the earnings number benefited by 7c on a lower tax rate than she had modeled. Home Depot now has even more riding on its performance in the seasonal peak of Q2, Champine tells investors in a post-earnings research note. She keeps a Hold rating on the shares with a $187 price target.
05/15/18
BARD
05/15/18
NO CHANGE
Target $215
BARD
Outperform
Home Depot weakness a buying opportunity, says Baird
Baird analyst Peter Benedict said softer seasonal sales impacted by weather was the reason for Home Depot's revenue miss in Q1. He said the company is seeing strong momentum thus far in May and 2018 guidance was maintained, so he would be a buyer of any weakness following the quarterly report. Benedict reiterated his Outperform rating and $215 price target on Home Depot shares, which are down about 2.7% to $186 in early pre-market trading.
05/09/18
CLVD
05/09/18
NO CHANGE
CLVD
Lowe's comp gap versus Home Depot could widen, says Cleveland Research
Cleveland Research said Lowe's (LOW) comp gap versus Home Depot (HD) could widen further given continued disruptions and inefficiencies in execution.
05/15/18
DBAB
05/15/18
NO CHANGE
Target $210
DBAB
Buy
Buying Home Depot after Q1 weakness has worked in past, says Deutsche Bank
Deutsche Bank analyst Mike Baker said that buying Home Depot shares following weather-related weakness in Q1 has previously been a good strategy. Following the company's latest Q1 report, he maintains a Buy rating on the stock and trimmed his price target to $210 from $212.
BA Boeing
$342.13

-2.26 (-0.66%)

04/26/18
04/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Buy from Neutral at UBS, to Outperform from Neutral at Macquarie, and to Neutral from Underweight at Atlantic Equities. 2. Boeing (BA) upgraded to Buy from Hold at Societe Generale. 3. Chipotle (CMG) upgraded to Buy from Neutral at BTIG, to Buy from Hold at Canaccord, to Neutral from Sell at Guggenheim, and to Market Perform from Underperform at Cowen. 4. Wex (WEX) upgraded to Buy from Neutral at Citi with analyst Peter Christiansen saying despite rallying 28% in the past six months, the stock should "grind further on continued organic momentum, though importantly on favorable margin dynamics." 5. Anthem (ANTM) upgraded to Overweight from Neutral at JPMorgan with analyst Gary Taylor saying he continues to be comfortable with the near-term trajectory of medical cost trends for the health insurance industry and maintains a long-term preference to own payors over providers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/18
BERN
05/09/18
NO CHANGE
BERN
U.S. exiting Iran deal minor negative for Boeing, Airbus, says Bernstein
Bernstein analyst Douglas Harned notes that President Trump announced that the U.S. will withdraw from the 2015 Iran nuclear accord, and will reinstate sanctions on that country. The analyst sees only minimal impact to commercial aerospace as neither Airbus (EADSY) nor Boeing (BA) will change production rates on this change, and the total number of orders affected represents just 2% of the companies' combined order backlogs. For defense contractors with significant Middle Eastern exposure, heightened regional tensions could drive increased demand for missile defense, in particular, but potentially also aircraft, ships, missiles, and vehicles, he contends. Harned believes Raytheon (RTN) is well positioned, having the highest exposure to missile defense and tactical missile sales to the Middle East, with Lockheed Martin (LMT) also a strong player.
04/26/18
WELS
04/26/18
NO CHANGE
Target $370
WELS
Market Perform
Boeing price target raised to $370 from $365 at Wells Fargo
Wells Fargo analyst Sam Pearlstein raised his price target for Boeing to $370 from $365 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
04/26/18
FBCO
04/26/18
NO CHANGE
Target $455
FBCO
Outperform
Boeing price target raised to $455 from $443 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Boeing to $455 from $443 as he is enthusiastic about both the macro revenue story and the micro margin story, the latter of which is driven by a generational initiative by management to streamline the aircraft production process and the supply chain behind it. The analyst reiterates an Outperform rating on the shares.
TSLA Tesla
$284.15

-7.69 (-2.64%)

05/03/18
BARD
05/03/18
NO CHANGE
Target $411
BARD
Outperform
Tesla weakness a buying opportunity, says Baird
Baird analyst Ben Kallo said Tesla's Q1 results beat on all metrics and recommend investors ignore all the noise about Musk not answering several questions on the conference call. He said investors should focus on the company's progress and recommended buying the shares. The analyst said demand remains strong, the company lowered its capex estimates, and the company continues to execute on its strategy. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
05/15/18
MSCO
05/15/18
NO CHANGE
Target $291
MSCO
Equal Weight
Tesla price target lowered to $291 from $376 at Morgan Stanley
Morgan Stanley analyst Adam Jonas made significant cuts to his near-term and long-term auto margin forecasts for Tesla following the company's Q1 report to reflect lingering manufacturing issues with the Model 3, which drove his price target on the stock down to $291 from $376. He has also delayed his forecast for the launch of Tesla's mobility-as-a-service network by roughly a year, to the middle of 2019, and increased his estimate for Tesla's capital raising to $3B from $2.5B. Jonas, who continues to expect Tesla will raise capital in the third quarter of this year, believes an added level of caution is prudent regarding Tesla and maintains an Equal Weight rating on the shares.
05/11/18
NOMU
05/11/18
NO CHANGE
Target $420
NOMU
Buy
Nomura lays out path to Tesla hitting $500 per share in two years
Nomura Instinet analyst Romit Shah believes the narrative on Tesla will shift over the next six months from insolvency risk and cash burn to market opportunity and growth. The analyst created a "Tesla Storyboard," which lays out the path to a $100B valuation, or $500 stock price, within two years. He keeps a Buy rating on Tesla with a $420 price target.
05/03/18
GSCO
05/03/18
NO CHANGE
Target $195
GSCO
Sell
Tesla cash levels lower than anticipated, says Goldman Sachs
Goldman Sachs analyst David Tamberrino kept his Sell rating and $195 price target on Tesla after its "mixed" Q1 earnings, saying that while gross margins were better than expected, the company's cash levels were below his forecasts. The analyst also cites "sparse" details around the improvement for Tesla's Fremont manufacturing facility and points to the company's rising net debt levels.
SQM SQM
$57.25

1.26 (2.25%)

02/26/18
MSCO
02/26/18
DOWNGRADE
Target $85
MSCO
Underweight
Morgan Stanley cuts Albemarle to sell with concerns on both supply and demand
As previously reported, Morgan Stanley analyst Vincent Andrews downgraded Albemarle (ALB) to Underweight, the firm's sell-equivalent rating, from Equal Weight citing his concerns on both the lithium supply and demand side. On the lithium demand side, bulls' electric vehicle penetration rate forecasts seem "aggressive, said Andrews. He also now has material concerns on the supply side following the recent Chilean government agreement with SQM (SQM), added Andrews, who lowered his price target on Albermarle to $85 from $100. Morgan Stanley analyst Javier Martinez de Olcoz Cerdan also downgraded SQM to Underweight this morning.
05/11/18
NOMU
05/11/18
NO CHANGE
Target $130
NOMU
Buy
Albemarle price target lowered to $130 from $141 at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov lowered his price target for Albemarle (ALB) to $130 and keeps a Buy rating on the shares. The company's Q1 results, while "solid," failed to point to "immediate and meaningful upside earnings revision in Lithium," Yefremov tells investors in a research note. The analyst still sees upside optionality to Albemarle's high-single-digit 2018 lithium price guidance, but notes the pace of increases will likely trail FMC Corporation (FCM) and SQM (SQM).
02/26/18
02/26/18
DOWNGRADE
Target $44

Underweight
SQM downgraded to Underweight with $44 price target at Morgan Stanley
As previously reported, Morgan Stanley analyst Javier Martinez de Olcoz Cerdan downgraded SQM (SQM) to Underweight from Equal Weight as he expects lithium prices to peak in 2018 then decline by 45% by 2021 as demand growth falls "far short" of sharp supply increases. Additionally, new supply is low cost and will transfer share from the high end to the low end of the cost curve, added the analyst. While cutting his rating to Underweight, Martinez de Olcoz Cerdan also called SQM the "best-quality lithium player globally" and increased his price target on the stock to $44 from $32.50. Morgan Stanley analyst Vincent Andrews also downgraded Albemarle (ALB) to Underweight this morning, citing his concerns on both the lithium supply and demand side.
03/08/18
HSBC
03/08/18
UPGRADE
Target $50
HSBC
Hold
SQM upgraded to Hold from Reduce at HSBC
HSBC analyst Alexandre Falcao upgraded SQM to Hold while lowering his price target for the shares to $50 from $52. The analyst views the valuation as "much more reasonable" following the recent pullback in the shares.
NTR Nutrien
$51.73

1.21 (2.40%)

05/09/18
05/09/18
UPGRADE
Target $58

Outperform
Nutrien upgraded to Outperform activity ramping, says Raymond James
As previously reported, Raymond James upgraded Nutrien to Outperform from Market Perform with a $58 price target. Analyst Steve Hansen believes broader NPK sector downside risks are now greatly outweighed by a longer-term, cyclical upside backdrop through 2020. Hansen thinks Nutrien's has the ability to pull multiple strategic "levers", optimize its portfolio, grow into strategic markets, and return capital to shareholders.
05/09/18
RAJA
05/09/18
UPGRADE
RAJA
Outperform
Nutrien upgraded to Outperform from Market Perform at Raymond James
05/08/18
STFL
05/08/18
NO CHANGE
STFL
Buy
Late start to spring sets up strong Q2 for Nutrien, says Stifel
Stifel analyst Vincent Anderson noted that Nutrien reported Q1 adjusted EPS that missed expectations, which he blames on the late start to spring in North America. However, that also sets up the company for a strong Q2 report, said Anderson. He maintains a Buy rating on Nutrien shares.
05/15/18
STFL
05/15/18
NO CHANGE
STFL
Hold
CF Industries, Mosaic price targets raised at Stifel
Stifel analyst Vincent Anderson raised his estimates for fertilizer producers as his new "NPK Affordability Index" indicates solid capacity for fertilizer markets to absorb new supply or else higher relative prices. Anderson continues to recommend Nutrien (NTR) as his sole Buy rating in the space and maintains a $60 price target on its shares. He raised his price target on CF Industries (CF) to $43 from $37 and upped his target on Mosaic (MOS) to $32 from $28, though he keeps Hold ratings on both of those two stocks.
HOLI Hollysys
$24.96

2.86 (12.94%)

05/15/18
SBSH
05/15/18
UPGRADE
SBSH
Buy
Hollysys upgraded to Buy from Neutral at Citi
Citi upgraded Hollysys Automation Technologies to Buy following last night's Q3 results and raised its price target for the shares to $26.30 from $25.90. The firm highlights the company's faster expansion into automation.
02/09/18
JPMS
02/09/18
DOWNGRADE
JPMS
Neutral
Hollysys downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Karen Li downgraded Hollysys Automation Technologies to Neutral following the company's Q2 results.
05/15/18
JPMS
05/15/18
UPGRADE
JPMS
Overweight
Hollysys upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Karen Li upgraded Hollysys Automation Technologies to Overweight citing an acceleration of industrial automation order growth and its expanding factory automation business. Citi this morning also upgraded Hollysys following the company's Q3 results.
09/28/17
DBAB
09/28/17
NO CHANGE
Target $25
DBAB
Buy
Hollysys target raised to $25 after management meetings at Deutsche Bank
After hosting non-deal roadshows with management, Deutsche Bank analyst Sky Hong raised Hollysys Automation Technologies' price target to $25 from $23. The shares, despite rebounding 25% from lows over the past three months, still do not reflect the company's "multi-year robust growth," Hong tells investors in a research note partially titled "another leg of re-rating looks well-deserved." The analyst keeps a Buy rating on Hollysys.
VRX Valeant
$21.53

0.73 (3.51%)

05/15/18
MZHO
05/15/18
UPGRADE
Target $27
MZHO
Buy
Mizuho compares Valeant portfolio to Mylan in upgrade to Buy
Mizuho analyst Irina Koffler upgraded Valeant Pharmaceuticals (VRX) to Buy from Neutral and raised her price target for the shares to $27 from $15. The stock closed yesterday down 4c to $20.81. Adjusting individual product growth estimates has made the analyst more constructive on Valeant's turnaround story. The company's portfolio now looks Mylan-like (MYL) in that 70% of revenue consists of stable products that are either consumer-focused, or older drugs that are already generic, Koffler tells investors in a research note. Further, the analyst sees growth potential from Valeant's pipeline, which she notes contains multiple catalysts in 2018-2020 and is not in her estimates. She thinks that in order for the stock to work over the next year, Valeant just needs to execute on its quarters and push through new product launches.
05/15/18
MZHO
05/15/18
UPGRADE
MZHO
Buy
Valeant upgraded to Buy from Neutral at Mizuho
05/14/18
BMOC
05/14/18
NO CHANGE
Target $20
BMOC
Market Perform
Valeant price target raised to $20 from $17 at BMO Capital
BMO Capital analyst Gary Nachman raised his price target on Valeant to $20, saying the company's "impressive" Q1 results demonstrate "good returns" on some of its strategic investments. Nachman also raised his FY18 EPS target to $3.42 from $3.12 to reflect the company's raised FY18 guidance. The analyst keeps his Market Perform rating amid continued uncertainty about sustainability of certain revenue drivers and potential contribution from its "key new product launches".
05/15/18
05/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Outperform from Market Perform at Telsey Advisory. 2. CBS (CBS) upgraded to Outperform from Market Perform at Bernstein with the firm saying it views the probability of a CBS-Viacom (VIAB) re-merger as close to zero, for many years to come. 3. Ulta Beauty (ULTA) upgraded to Outperform from Perform at Oppenheimer with analyst Rupesh Parikh saying he still sees the potential for more gains and outperformance from current levels. 4. Valeant (VRX) upgraded to Buy from Neutral at Mizuho with analyst Irina Koffler saying adjusting individual product growth estimates has made her more constructive on Valeant's turnaround story. 5. Scotts Miracle-Gro (SMG) upgraded to Buy from Hold at SunTrust with analyst William Chappell saying he believes the bottom in the stock price has been reached, leading to its usual "counter seasonal trend of outperformance" given that the stock has outperformed the S&P500 from June to January in the past 11 of 15 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VIPS Vipshop
$12.08

-3.02 (-20.00%)

02/13/18
02/13/18
UPGRADE
Target $20

Outperform
Vipshop upgraded to Outperform on improved growth prospects at Macquarie
As previously reported, Macquarie analyst Wendy Huang upgraded Vipshop (VIPS) to Outperform from Neutral following the company's revenue and earnings beat in Q4. Huang believes the company's recently announced tie-up with Tencent (TCEHY) and JD.com (JD) has strengthened its growth prospects, as it can accelerate user acquisitions and help the company attract more brands and better products to sell. Huang, who also reiterated JD.com as her top pick among e-commerce names, has a $20 price target on Vipshop shares.
02/13/18
02/13/18
UPGRADE
Target $20

Outperform
Follow-up: Vipshop upgraded to Outperform on growth prospects at Macquarie
As previously reported, Macquarie upgraded Vipshop to Outperform from Neutral following the Q4 beat and better than expected Q1 guidance. Analyst Wendy Huang raised Vipshop's price target to $20 from $9 and increased estimates due to stronger growth prospects Huang believes the tie-ups with Tencent and JD.com will drive accelerated user acquisitions, generate synergies in the logistics business, and enable Vipshop to attract more brands and better SKUs.
02/14/18
BNCH
02/14/18
NO CHANGE
Target $24
BNCH
Buy
Vipshop price target raised to $24 on 'milestone' partnership at Benchmark
Benchmark analyst Fawne Jiang raised her price target on Vipshop (VIPS) to $24 from $12, stating that its partnership with Tencent (TCEHY) and JD.com (JD) is a "milestone" step with both substantial financial benefits and the potential to unleash Vipshop's strategic value as an e-commerce asset. Jiang reiterated her Buy rating on Vipshop shares following the company's "solid" Q4 report.
05/15/18
LYON
05/15/18
DOWNGRADE
LYON
Underperform
Vipshop downgraded to Underperform from Buy at CLSA
A Agilent
$62.52

-6.72 (-9.71%)

05/15/18
BARD
05/15/18
NO CHANGE
Target $77
BARD
Outperform
Agilent core growth slowing, but underlying business healthy, says Baird
Baird analyst Catherine Ramsey Schulte said Agilent's Q2 growth hit the guidance midpoint, but fell short of expectations due to unforeseen headwinds in China and ICP/MS shipment timing. She noted management remains bullish on end-market outlooks and she still believes they are being conservative with guidance. Although the company's core growth is slowing, she said the underlying business is healthy. Schulte reiterated her Outperform rating and lowered her price target to $77 from $78 on Agilent shares.
05/15/18
JEFF
05/15/18
NO CHANGE
Target $80
JEFF
Buy
Agilent pullback a buying opportunity, says Jefferies
Jefferies analyst Brandon Couillard recommends using the post-earnings pullback in shares of Agilent Technologies as a buying opportunity. Guidance was maintained, despite dilution from Lasergen, and does not yet capture accretion from the pending AATI deal, Couillard tells investors in a research note. He sees no reason to alter his positive thesis and keeps a Buy rating on Agilent with a slightly reduced price target of $80.
04/09/18
04/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he sees room for positive earnings revisions for GM, Ford (F) and Fiat Chrysler (FCAU) as investors better understand the impact on U.S. pick-up truck sales from a potential passage of a U.S. infrastructure bill. 2. TD Ameritrade (AMTD) upgraded to Buy from Neutral at BofA/Merrill with analyst Michael Carrier saying he views TD Ameritrade's near-term outlook as attractive given healthy new net asset growth, higher interest rates, and strong DARTs. 3. Comerica (CMA) upgraded to Outperform from Neutral at Wedbush with analyst Peter Winter saying he sees several levers that should drive above average earnings per share growth over the next two years, including margin expansion, potential resumption of loan growth, and above average capital returns. 4. Agilent (A) upgraded to Buy from Neutral at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools. 5. Discover (DFS) and Ally Financial (ALLY) were upgraded to Equal Weight from Underweight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/18
COWN
05/15/18
UPGRADE
COWN
Outperform
Agilent upgraded to Outperform from Market Perform at Cowen

TODAY'S FREE FLY STORIES

05:55
05/28/18
05/28
05:55
05/28/18
05:55
General news
Oil Action: Front-month WTI futures are down 1.6% »

Oil Action: Front-month…

PM

Philip Morris

$80.34

-1.27 (-1.56%)

04:55
05/28/18
05/28
04:55
05/28/18
04:55
Conference/Events
Philip Morris management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

03:05
05/28/18
05/28
03:05
05/28/18
03:05
General news
FX Update: The euro has firmed »

FX Update: The euro has…

KORS

Michael Kors

$68.63

0.25 (0.37%)

, LULU

Lululemon

$106.18

-0.19 (-0.18%)

11:07
05/26/18
05/26
11:07
05/26/18
11:07
Periodicals
Dollar Tree looks interesting, Barron's says »

Next week, another 20…

KORS

Michael Kors

$68.63

0.25 (0.37%)

LULU

Lululemon

$106.18

-0.19 (-0.18%)

GME

GameStop

$12.64

-0.1 (-0.78%)

DLTR

Dollar Tree

$95.23

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 12

    Jun

  • 14

    Jun

  • 26

    Jun

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

, QCOM

Qualcomm

$59.95

0.85 (1.44%)

10:58
05/26/18
05/26
10:58
05/26/18
10:58
Periodicals
Kraft Heinz, J&J among safe, 'solid' dividend stocks, Barron's says »

Kraft Heinz (KHC),…

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

QCOM

Qualcomm

$59.95

0.85 (1.44%)

MRK

Merck

$59.08

-0.03 (-0.05%)

TGT

Target

$71.22

0.28 (0.39%)

OMC

Omnicom

$71.98

-0.1 (-0.14%)

CCL

Carnival

$64.27

0.12 (0.19%)

JNJ

Johnson & Johnson

$121.40

0.06 (0.05%)

MMM

3M

$198.98

-0.38 (-0.19%)

LLY

Eli Lilly

$82.75

0.05 (0.06%)

VLO

Valero

$118.81

-3.06 (-2.51%)

EMR

Emerson

$72.50

-0.77 (-1.05%)

WBA

Walgreens Boots Alliance

$63.52

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 19

    Jun

  • 10

    Sep

  • 23

    Oct

MU

Micron

$61.33

-0.15 (-0.24%)

10:48
05/26/18
05/26
10:48
05/26/18
10:48
Periodicals
Micron can solve low valuation, Barron's says »

Micron's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ATUS

Altice USA

$18.50

-0.05 (-0.27%)

10:40
05/26/18
05/26
10:40
05/26/18
10:40
Periodicals
Altice's spinoff could be winning bet, Barron's says »

On June 8, Altice will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

MU

Micron

$61.33

-0.15 (-0.24%)

, XLNX

Xilinx

$69.63

0.88 (1.28%)

10:35
05/26/18
05/26
10:35
05/26/18
10:35
Periodicals
AI revolution just getting started, Barron's says »

Artificial Intelligence…

MU

Micron

$61.33

-0.15 (-0.24%)

XLNX

Xilinx

$69.63

0.88 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:08
05/26/18
05/26
08:08
05/26/18
08:08
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

HMC

Honda

$32.04

-0.34 (-1.05%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$11.51

-0.11 (-0.95%)

GM

General Motors

$38.30

-0.09 (-0.23%)

TM

Toyota

$129.97

-2.47 (-1.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

BAC

Bank of America

$30.16

-0.03 (-0.10%)

C

Citi

$68.42

-0.86 (-1.24%)

GS

Goldman Sachs

$235.05

-1.1 (-0.47%)

JPM

JPMorgan

$110.62

-0.64 (-0.58%)

MS

Morgan Stanley

$53.02

-0.96 (-1.78%)

USB

U.S. Bancorp

$50.54

-0.14 (-0.28%)

WFC

Wells Fargo

$54.91

0.25 (0.46%)

TWTR

Twitter

$33.64

0.11 (0.33%)

AA

Alcoa

$47.92

-1.26 (-2.56%)

CENX

Century Aluminum

$16.27

-0.07 (-0.43%)

AOBC

American Outdoor Brands

$12.53

0.05 (0.40%)

RGR

Sturm, Ruger

$63.10

0.5 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 27

    Jul

  • 10

    Sep

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 15

    Jul

  • 15

    Oct

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.